geneSet	description	link	size	overlap	expect	enrichmentRatio	pValue	FDR	overlapId	userId
hsa05168	Herpes simplex infection	http://www.kegg.jp/kegg-bin/show_pathway?hsa05168+10379+3107+3133+3134+3434+3569+3600+3665+4938+4939+4940+5371+5610+6041+6352+6772	166	16	2.0622825906907405	7.758393574297188	1.0859624310910476e-10	3.4099220336258895e-8	10379;3107;3133;3134;3434;3569;3600;3665;4938;4939;4940;5371;5610;6041;6352;6772	OAS2;IL6;IFIT1;STAT1;OAS1;IRF9;OAS3;IRF7;HLA-E;RNASEL;EIF2AK2;HLA-F;CCL5;IL15;HLA-C;PML
hsa04621	NOD-like receptor signaling pathway	http://www.kegg.jp/kegg-bin/show_pathway?hsa04621+10135+10379+10392+115362+3428+3569+3665+4938+4939+4940+6041+6352+6772+79792	158	14	1.9628954778863672	7.132320675105486	5.606204833696893e-9	8.801741588904122e-7	10135;10379;10392;115362;3428;3569;3665;4938;4939;4940;6041;6352;6772;79792	OAS2;IL6;STAT1;OAS1;GBP5;IRF9;OAS3;IRF7;GSDMD;NAMPT;RNASEL;IFI16;NOD1;CCL5
hsa05164	Influenza A	http://www.kegg.jp/kegg-bin/show_pathway?hsa05164+10379+3569+3665+4938+4939+4940+5371+5610+6041+6352+6772+8743+91543	157	13	1.9504720887858207	6.665053078556263	4.757262650478822e-8	4.9792682408345e-6	10379;3569;3665;4938;4939;4940;5371;5610;6041;6352;6772;8743;91543	OAS2;RSAD2;IL6;STAT1;OAS1;IRF9;OAS3;IRF7;RNASEL;EIF2AK2;TNFSF10;CCL5;PML
hsa05169	Epstein-Barr virus infection	http://www.kegg.jp/kegg-bin/show_pathway?hsa05169+10379+3107+3133+3134+3569+3665+4938+4939+4940+5610+6772+9541+9636	184	13	2.2859035945005797	5.687028985507246	3.1060756966461156e-7	2.4382694218672007e-5	10379;3107;3133;3134;3569;3665;4938;4939;4940;5610;6772;9541;9636	OAS2;IL6;STAT1;ISG15;OAS1;IRF9;OAS3;IRF7;HLA-E;EIF2AK2;CIR1;HLA-F;HLA-C
hsa05160	Hepatitis C	http://www.kegg.jp/kegg-bin/show_pathway?hsa05160+10379+3434+3665+4938+4939+4940+5610+6041+6772	113	9	1.403842968361769	6.410973451327434	9.154467448757586e-6	5.749005557819764e-4	10379;3434;3665;4938;4939;4940;5610;6041;6772	OAS2;IFIT1;STAT1;OAS1;IRF9;OAS3;IRF7;RNASEL;EIF2AK2
hsa05162	Measles	http://www.kegg.jp/kegg-bin/show_pathway?hsa05162+10379+3569+3665+4938+4939+4940+5610+6772+8743	119	9	1.4783833029650488	6.087731092436975	1.3972483736024444e-5	7.312266488519459e-4	10379;3569;3665;4938;4939;4940;5610;6772;8743	OAS2;IL6;STAT1;OAS1;IRF9;OAS3;IRF7;EIF2AK2;TNFSF10
hsa05203	Viral carcinogenesis	http://www.kegg.jp/kegg-bin/show_pathway?hsa05203+10379+3107+3133+3134+3665+5610+8347+8361+8362+8366	176	10	2.1865164816962066	4.573484848484849	5.5165923236399905e-5	0.002474585699461367	10379;3107;3133;3134;3665;5610;8347;8361;8362;8366	IRF9;IRF7;HLA-E;HIST1H4B;HIST1H4K;HIST1H2BC;HIST1H4F;EIF2AK2;HLA-F;HLA-C
hsa05167	Kaposi sarcoma-associated herpesvirus infection	http://www.kegg.jp/kegg-bin/show_pathway?hsa05167+10379+3107+3133+3134+3569+3665+5610+6772+9976	170	9	2.111976147092927	4.2614117647058825	2.291266562012284e-4	0.008993221255898215	10379;3107;3133;3134;3569;3665;5610;6772;9976	IL6;STAT1;IRF9;IRF7;HLA-E;CLEC2B;EIF2AK2;HLA-F;HLA-C
hsa05332	Graft-versus-host disease	http://www.kegg.jp/kegg-bin/show_pathway?hsa05332+3107+3133+3134+3569	34	4	0.42239522941858537	9.469803921568628	7.684647515822096e-4	0.026810881332979312	3107;3133;3134;3569	IL6;HLA-E;HLA-F;HLA-C
